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Abstract
This paper investigates the dynamics of immune response and autoimmunity with particular
emphasis on the role of regulatory T cells (Tregs), T cells with different activation thresholds,
and cytokines in mediating T cell activity. Analysis of the steady states yields parameter regions
corresponding to regimes of normal clearance of viral infection, chronic infection, or autoimmune
behaviour, and the boundaries of stability and bifurcations of relevant steady states are found in
terms of system parameters. Numerical simulations are performed to illustrate different dynamical
scenarios, and to identify basins of attraction of different steady states and periodic solutions,
highlighting the important role played by the initial conditions in determining the outcome of
immune interactions.
1 Introduction
Autoimmune disease is a pathological condition characterised by the failure of the immune system to
efficiently discriminate between self-antigens and foreign antigens, resulting in unwanted destruction
of healthy organ cells. In the case of normal functioning, recognition of foreign epitopes presented on
antigen presenting cells (APCs) to T lymphocytes results in proliferation and effector function from
T cells, while cross-reactivity between epitopes leads to the possibility of T cell response against self-
antigens [1, 2]. T cells with high level of self-reactivity are removed from the system by two different
mechanisms: central tolerance and peripheral tolerance. Central tolerance is associated with the
removal of autoreactive T cells during their development in the thymus, while the peripheral tolerance
is usually controlled by regulatory T cells [3]. One should note that it is important for autoreactive T
cells to be present in the periphery to maintain effective T cell repertoire through generation of new
peripheral T cells, and the stimulus produced by the healthy cells would normally not be sufficient to
trigger activation of autoreactive T cells.
Clinical observations suggest that autoimmune disease is usually focused in a specific organ or
part of the body, such as central nervous system in multiple sclerosis, retina in the case of uveitis,
or pancreatic β-cells in insulin-dependent diabetes mellitus type-1 [4, 5, 6]. Significant efforts have
∗Corresponding author: K.Blyuss@sussex.ac.uk
1
ar
X
iv
:1
81
0.
11
81
8v
1 
 [q
-b
io.
QM
]  2
8 O
ct 
20
18
been made to pinpoint causes of autoimmune disease, and a large number of contributing factors
have been identified, which include genetic predisposition, age, previous immune challenges, exposure
to pathogens etc. [7]. One should note that even in the presence of genetic predisposition [8, 9, 10],
further environmental triggers are required to initiate the onset of autoimmune disease, with infections
being one of the main contributors [11, 12]. Spontaneous autoimmunity has been associated with
the dysregulation of immune response against Epstein-Barr virus in patients with multiple sclerosis
[13, 14, 15], while infections with Coxsackie viruses are associated with type-1 diabetes [16, 17]. A
number of distinct mechanisms have been identified that explain how an infection of the host with
a pathogen can subsequently trigger the onset of autoimmune disease. These mechanisms include
bystander activation [18] and molecular mimicry [19, 16], which is particularly important in the context
of autoimmunity caused by viral infections.
In terms of mathematical modelling of immune response and possible onset of autoimmunity, some
of the early models analysed interactions between regulatory and effector T cells without investigating
specific causes of autoimmunity, but instead focusing on T cell vaccination [20]. Borghans and De Boer
[21] and Borghans et al. [22] showed how autoimmune dynamics, that they defined as above-threshold
oscillations in the number of autoreactive cells, can appear in such models. Le´on et al. [23, 24, 25]
have studied interactions between different T cells, and how they can affect regulation of immune
response and control of autoimmunity. Carneiro et al. [26] have presented on overview of that work
and compared two possible mechanisms of immune self-tolerance that are either based on control by
specific regulatory T cells, or result from tuning of T cell activation thresholds. Iawmi et al. [27, 28]
have analysed a model of immune response to a viral infection with an emphasis on explicitly including
the virus population, and the effects of different forms of the growth function for susceptible cells on
autoimmune dynamics. Despite this model’s ability to demonstrate the emergence of autoimmunity,
since it does not allow for a viral expansion, it cannot support a regime of normal viral clearance.
Alexander and Wahl [29] have focused on how interactions of professional APCs with effector and
regulatory T cells can control autoimmune response. Burroughs et al. [30, 31] have demonstrated how
autoimmunity can arise through bystander activation mediated by cytokines. An excellent overview
of some of the latest development in mathematical modelling of autoimmune disease can be found in
a special issue on “Theories and modelling of autoimmunity” [32].
Since T cells are know to be fundamental for the dynamics of autoimmunity, several different
methodologies have been proposed for the analysis of various roles they play in coordinating im-
mune response. Experimental evidence suggests that a major component in controlling autoimmune
behaviour is provided by regulatory T cells, which are activated by autoantigens and act to shut
down immune responses [33, 34, 35], while impairment in the function of regulatory T cells results
in autoimmune disease [36, 37]. To model this process, Alexander and Wahl [29] and Burroughs et
al. [30, 31] have explicitly included a separate compartment for regulatory T cells that are activated
by autoantigens and suppress the activity of autoreactive T cells. Another theoretical approach sup-
ported by experimental evidence is the idea that T cells have the capacity to adjust their activation
threshold for response to stimulation by autoantigens depending on various environmental conditions
or endogenous stochastic variation, which allows them to perform a variety of different immune func-
tions. The associated framework of tunable activation thresholds was proposed for analysis of thymic
[38] and peripheral T cell dynamics [39, 40], and has been subsequently used to analyse differences in
activation/response thresholds that are dependent on the activation state of the T cell [41]. van den
Berg and Rand [42] and Scherer et al. [43] have developed and analysed stochastic models for tuning
of activation thresholds. The importance of tuning lies in the fact that it provides an effective mecha-
nism for improving sensitivity and specificity of T cell signalling in a noisy environment [44, 45], and
both murine and human experiments have confirmed that activation of T cells can indeed dynamically
change during their circulation [46, 47, 48, 49]. It is noteworthy that the need for activation thresholds
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for T cells can be derived directly from the first principles of signal detection theory [50].
To model the dynamics of immune response to a viral infection and possible onset of autoimmu-
nity, Blyuss and Nicholson [51, 52] have proposed and analysed a mathematical model that includes
two types of T cells with different activation thresholds and allows for a biologically realistic situation
where infection and autoimmune response occur in different organs of the host. Depending on param-
eter values, this model can exhibit the regime of normal viral clearance, a chronic infection, and an
autoimmune state represented by endogenous oscillations in cell populations, associated with episodes
of high viral production followed by long periods of quiescence. Such behaviour, associated in the
clinical practice with relapses and remissions, has been observed in a number of autoimmune diseases,
such as MS, autoimmune thyroid disease, and uveitis [53, 54, 55]. Despite its successes, this model has
several limitations. One of those is the fact that the periodic oscillations in the model are only possible
when the amount of free virus and the number of infected cells are also exhibiting oscillations, while
in laboratory and clinical situations, one rather observes a situation where autoimmunity follows full
clearance of the initial infection. Another issue is that this model does not exhibit bi-stability, which
could explain clinical observations suggesting that patients with very similar parameters of immune
response can have significantly different course and outcome of the infection.
Bi-stability between different dynamical states is an extremely important property of various bi-
ological systems, and it has already been studied in a variety of contexts, including neural networks
[56, 57, 58], gene regulatory networks [59, 60, 61], within-cell dynamics of RNA interference [62],
and immune dynamics [63, 27]. In immunology, bifurcations and multi-stability have been studied
in the context of T cell differentiation [64, 65], including the role of cytokines [66]. Ngina et al. [67]
have investigated the dynamics of HIV from the perspective of interactions between HIV virions and
CD8+ T cells, and identified a region of bi-stability associated with the backward bifurcation, where
the system can reach either a virion-free or endemic equilibrium depending on the initial conditions.
This observation has profound implications for developing an effective anti-retroviral therapy. Due
an important role played by immune response in mediating the onset and development of cancer, a
number of researchers have investigated bifurcations and possible multi-stability that can arise in these
interactions. Piotrowska [68] has analysed a model of immune response to malignant tumours with
an emphasis on the role of time delay associated with developing immune response. This model was
shown to exhibit bi-stability, with the dynamics being determined by the initial size of the tumour.
Li and Levine [69] have investigated a cytokine-mediated bi-stability between immune-promoting and
immune-suppressing states in the model of cancer-related inflammation. Anderson et al. [70] have
looked into interactions between cytokines and CD4+ T cells for the purpose of immunotherapy. The
bi-stability was shown to correspond to two simultaneously present levels at which the tumor can
stabilise depending on the initial conditions.
In the specific context of autoimmunity, Le´on et al. [23] have highlighted the importance of bi-
stability between steady states with high populations of either regulatory, or effector T cells for effective
representation of the adoptive transfer of tolerance. Roy et al. [71] have developed a general kinetic
model to capture the role of vitamin D in immunomodulatory responses, and they demonstrated that
vitamin D extends the region of bi-stability, thus allowing immune regulation to be more robust with
respect to changes in pathogenic stimulation. Baker et al. [72] have analysed the dynamics of immune
response during rheumatoid arthritis with particular emphasis on the effects of cytokines on bi-stability
and treatment. Rapin et al. [73] have proposed a simple model of autoimmunity that displays a bi-
stability between stable steady states corresponding to a healthy state and autoimmunity. The authors
have shown how the system can be switched back to the healthy steady state by immunotherapy aimed
at destabilising an autoimmune steady state.
In this paper, we will show how inclusion of regulatory T cells and the cytokine mediating T cell
activity can allow one to overcome above-mentioned difficulties and provide a more realistic represen-
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tation of various regimes in the dynamics of immune response. In the next section we will introduce
the model and discuss its basic properties. Section 3 contains systematic analysis of all steady states,
including conditions for their feasibility and stability. In Section 4 we perform extensive bifurcation
analysis of the model and illustrate various types of behaviour that can be exhibited by the system
depending on parameters and initial conditions, which includes identification of basins of attraction
of various states. The paper concludes in Section 5 with the discussion of results.
2 Model derivation
To analyse the dynamics of immune response to infection and possible onset of autoimmunity, we use
an approach similar to some of the earlier models of immune response [51, 52, 74, 75]. The underlying
idea is the mechanism of molecular mimicry, where immune response against an infection can lead to
a breakdown of immune tolerance due to cross-reaction with one or more self-antigens that share some
of their immunological characteristics with a pathogen [16, 19]. Experimental evidence suggests that
while antibodies are important in a wider picture of immune response to viral infections, within the
context of autoimmunity, B cells can be dispensable, so that autoimmune disease can develop even in
their absence [76]. Moreover, it has been shown in some studies that the development of antibodies
can itself depend on prior interactions of T cells with a pathogen [77]. Hence, in this paper we rather
focus on the role of T cells and associated cytokines.
We consider a situation where both infection and autoimmune response are targeting the same
organ of the body, and the population of healthy cell in this organ is denoted by A(t). These cells
are assumed to follow logistic growth with the proliferation rate r and the carrying capacity N in
the absence of infection or autoimmune response, as is common in models of viral dynamics [27, 78].
At the same time, one should be mindful of the fact that different functional forms of the growth
of healthy cells can also have an effect on autoimmune dynamics, as has been shown by Iwami et
al. [27, 28].
During a viral infection, some number of healthy cells become infected by free virus particles, at
which point they move to the compartment of infected cells, denoted by F (t). After a certain period
of time, these infected cells will be producing virions, or free virus particles, V (t) at a rate k, and the
rate of natural clearance of virions is denoted by c. These virions then go on to infect other as yet
uninfected cells at a rate β, which is an effective rate incorporating time constants associated with
various biological processes, such as the movement of virions, cell entry, and an eclipse phase, during
which the cells are infected but are not yet recognised as such by the immune system.
In terms of immune dynamics, T cell response originates in the lymph nodes. Stimulation of na¨ıve
T cells results in their proliferation, differentiation into activated T cells, and subsequent migration to
the infected tissue. Once activated, T cells bearing the CD8+ receptor become cytotoxic T cells that
are able to destroy infected cells, whereas if they have a CD4+ receptor, they turn into helper T cells
[79, 80]. Tregs perform an important role of suppressing the autoreactive T cells, and are a part of
CD4+ T cell population [81, 82, 83]. Since in this paper we are trying to understand self and non-self
discrimination mechanisms of the immune response, we consider two populations of na¨ıve CD8+ T
cells that respond to self-antigens and foreign antigens, while focusing on one population of CD4+ T
cells representing regulatory T cells. Kim et al. [80] have considered a situation where each population
of na¨ıve T cells is maintained at a certain level supported by homeostasis in the absence of infection.
Burroughs et al. [84, 30] and Segel et al. [20] in their models have instead considered a constant influx
of new T cells from the thymus. In this model, for simplicity, we consider a single population of na¨ıve
T cells which includes Tregs, foreign-reactive and self-reactive T cells, and, similarly to earlier work,
the population of these na¨ıve T cells is assumed to be maintained at a certain level by homeostasis
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Figure 1: A schematic diagram of immune response to an infection. Blue circles indicate host cells (un-
infected and infected cells), red circles denote different T cells (na¨ıve, regulatory, normal activated, and
autoreactive T cells), yellow circle shows cytokines (interleukin 2), and grey indicates virus particles
(virions). Single arrow-headed and bar-headed lines indicate, respectively, production/proliferation
and destroying of one cell population from/by another. Double arrows indicate natural clearance.
[51, 27, 28, 78]. It is thus assumed that in the absence of infection, these cells are produced at
a constant rate λin, and they die at a rate din. Once activated, these cells differentiate into either
regulatory T cells, whose main role is the control of immune response against self- and foreign antigens
[79, 35], as well as prevention of autoimmune disease [35, 29, 26, 85], or effector cells that are able
to eliminate infected cells. We denote by α the rate at which na¨ıve T cells are activated. Since Tin
includes different kinds of na¨ıve T cells, it is assumed that a constant proportion p1 of them will
develop into regulatory T cells Treg, and a proportion p2 will become normal activated T cells Tnor
that are able to recognise infected cells expressing foreign antigen and destroy these cells at rate µF .
The remaining proportion (1 − p1 − p2) of T cells will become autoreactive cells Taut with a lower
threshold for activation by healthy cells, hence, they will be destroying both infected and healthy cells
at rate µa. Unlike the work by Blyuss and Nicholson [51, 52], Burroughs et al. [30] and Kim et al. [80]
have not explicitly modelled the production of autoreactive T cells from normal activated T cells, and
in the present model we also do not include this feature, as the model already accounts for the influx
of each population of T cells directly to the tissue.
Similarly to other models of autoimmune dynamics [30, 84, 86], regulatory T cells in our model are
assumed to have their own homeostatic mechanism, and they are assumed to be produced at constant
rate λr and die at rate dr. One of the main effects of regulatory T cells is to suppress the proliferation
of autoreactive T cells. Part of this suppression occurs through the inhibition of interleukin 2 (IL-2)
by T cells [87, 88]. Moreover, there is evidence for both cell-to-cell inhibition, and soluble mediators
5
such as IL-10 and TNF-β [84, 30, 33, 80]. There is some experimental evidence suggesting that the
suppression by Tregs is antigen-specific [89, 90, 91], which implies that Tregs are able to discriminate
between T cells responding to self-antigens and T cells responding to foreign antigen [35]. Le´on et
al. [23] and Carneiro et al. [92] have proposed a model that considers antigen-specific suppression
by Tregs, thus endowing Tregs with a mechanism for self/non-self discrimination. Baecher-Allan et
al. [93] have proposed a model for the T cell receptor (TCR) signal strength, where Tregs suppress
the activation of autoreactive T cells, while the T cells reactive to foreign antigen are refractory to the
suppression. Thus, in this paper we only consider direct suppression of autoreactive T cells by Tregs,
which is assumed to occur at rate δ, and, unlike the work by Burroughs et al. [30] and Kim et al. [80],
we are assuming Tregs do not suppress the normal activated T cells Tnor. Among various cytokines
involved in the process of immune response, a particularly important role is played by IL-2, to be
denoted by I(t), which is an essential factor in the growth of T cells. Whilst this cytokine promotes
the growth of both regulatory and effector T cells, regulatory T cells do not secrete IL-2 [79, 30, 84].
Therefore, in this model we assume that Tnor and Taut produce IL-2 at rates σ1 and σ2. On the other
hand, whilst regulatory T cells do not produce IL-2, similar to other T cells they need this cytokine for
their activation and proliferation [94, 95]. Thus, we assume that IL-2 promotes proliferation of Treg,
Tnor and Taut at rates ρ1, ρ2 and ρ3, respectively. Although it is also possible to include in the model
inhibition of IL-2 by T cells [84, 95], our analysis shows that this would not qualitatively change the
behaviour of the model.
With the above assumptions, the model for dynamics of immune response to a viral infection with
account for Tregs, T cells with different activation thresholds and IL-2, as illustrated in Fig. 1, takes
the form
dA
dt
= rA
(
1− A
N
)
− βAV − µaTautA,
dF
dt
= βAV − dFF − µFTnorF − µaTautF,
dTin
dt
= λin − dinTin − αTinF,
dTreg
dt
= λr − drTreg + p1αTinF + ρ1ITreg,
dTnor
dt
= p2αTinF − dnTnor + ρ2ITnor,
dTaut
dt
= (1− p1 − p2)αTinF − daTaut − δTregTaut + ρ3ITaut,
dI
dt
= σ1Tnor + σ2Taut − diI,
dV
dt
= kF − cV,
(1)
with 0 ≤ p1 + p2 ≤ 1. Introducing non-dimensional variables
tˆ = rt, A = NAˆ, F = NFˆ , Tin =
λin
din
Tˆin, Treg =
λin
din
Tˆreg,
Tnor =
λin
din
Tˆnor, Taut =
λin
din
Tˆaut, I =
λin
din
Iˆ , V = NVˆ ,
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yields a rescaled model
dA
dt
= A (1−A)− βAV − µaTautA,
dF
dt
= βAV − dFF − µFTnorF − µaTautF,
dTin
dt
= din (1− Tin)− αTinF,
dTreg
dt
= λr − drTreg + p1αTinF + ρ1ITreg,
dTnor
dt
= p2αTinF − dnTnor + ρ2ITnor,
dTaut
dt
= (1− p1 − p2)αTinF − daTaut − δTregTaut + ρ3ITaut,
dI
dt
= σ1Tnor + σ2Taut − diI,
dV
dt
= kF − cV,
(2)
where
βˆ =
βN
r
, µˆa =
µaλin
rdin
, dˆF =
dF
r
, µˆF =
µFλin
rdin
, dˆin =
din
r
,
αˆ =
αN
r
, λˆr =
λrdin
λinr
, dˆn =
dn
r
, dˆa =
da
r
, ρˆi =
ρiλin
rdin
, i = 1, 2, 3,
δˆ =
δλin
rdin
, σˆ1 =
σ1
r
, σˆ2 =
σ2
r
, dˆi =
di
r
, kˆ =
k
r
, cˆ =
c
r
, dˆr =
dr
r
,
and all hats in variables and parameters have been dropped for simplicity of notation. The model (2)
is clearly well-posed, i.e. its solutions remain non-negative for t ≥ 0 for any non-negative initial
conditions.
3 Steady states and their stability
As a first step in the analysis of model (2), we look at its steady states
S∗ =
(
A∗, F ∗, T ∗in, T
∗
reg, T
∗
nor, T
∗
aut, I
∗, V ∗
)
,
that can be found by equating to zero the right-hand sides of equations (2) and solving the resulting
system of algebraic equations. High dimensionality of the system (2) results in a large number of
possible steady states, so we now systematically study all of them. First, we consider a situation
where at a steady state, there is no free virus population, i.e. V ∗ = 0, which immediately implies
F ∗ = 0 and T ∗in = 1. In this case there are four possible steady states depending on whether T
∗
nor and
T ∗aut are each equal to zero or being positive. If T ∗nor = T ∗aut = 0, there are two steady states
S∗1 =
(
0, 0, 1,
λr
dr
, 0, 0, 0, 0
)
, S∗2 =
(
1, 0, 1,
λr
dr
, 0, 0, 0, 0
)
,
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of which S∗1 is always unstable, and S∗2 is stable if cdF − kβ > 0, unstable if cdF − kβ < 0, and
undergoes a steady-state bifurcation at cdF − kβ = 0. For T ∗nor 6= 0 and T ∗aut = 0, we again have two
steady states
S∗3 =
(
0, 0, 1,
λrρ2
ρ2dr − ρ1dn ,
didn
σ1ρ2
, 0,
dn
ρ2
, 0
)
,
S∗4 =
(
1, 0, 1,
λrρ2
ρ2dr − ρ1dn ,
didn
σ1ρ2
, 0,
dn
ρ2
, 0
)
,
but they are both unstable for any values of parameters.
In the case when T ∗nor = 0 and T ∗aut 6= 0, we have steady states S∗5 and S∗6 ,
S∗5 =
(
0, 0, 1, T ∗reg, 0,
di
(
da + δT
∗
reg
)
ρ3σ2
,
da + δT
∗
reg
ρ3
, 0
)
,
S∗6 =
(
1− µadi
(
da + δT
∗
reg
)
ρ3σ2
, 0, 1, T ∗reg, 0,
di
(
da + δT
∗
reg
)
ρ3σ2
,
da + δT
∗
reg
ρ3
, 0
)
,
where
T ∗reg =
drρ3 − ρ1da ±
√
(drρ3 − ρ1da)2 − 4ρ1δλrρ3
2ρ1δ
.
The steady state S∗5 (respectively, S∗6) is stable if the following conditions hold
P <
da + δT
∗
reg
ρ3
<
dn
ρ2
, δρ1
(
T ∗reg
)2
> λrρ3,
ρ3λ
2
r + ρ3diλrT
∗
reg − ρ3dida
(
T ∗reg
)2 − δ(ρ1da + ρ3di) (T ∗reg)3 − ρ1δ2 (T ∗reg)4 > 0,
where
P =

σ2
µadi
, for S∗5 ,
σ2 (βk − cdF )
µadi (c+ βk)
, for S∗6 .
This steady state undergoes a steady-state bifurcation if
da + δT
∗
reg
ρ3
= P, or
da + δT
∗
reg
ρ3
=
dn
ρ2
, or δρ1
(
T ∗reg
)2
= λrρ3,
and a Hopf bifurcation if
P <
da + δT
∗
reg
ρ3
<
dn
ρ2
, δρ1
(
T ∗reg
)2
> λrρ3,
ρ3λ
2
r + ρ3diλrT
∗
reg − ρ3dida
(
T ∗reg
)2 − δ(ρ1da + ρ3di) (T ∗reg)3 − ρ1δ2 (T ∗reg)4 = 0.
The steady state with T ∗nor 6= 0 and T ∗aut 6= 0 only exists for a particular combination of parameters,
namely, when
δρ22λr = (ρ3dn − ρ2da)(ρ2dr − ρ1dn),
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and is always unstable.
When V ∗ 6= 0, all other state variables are also non-zero. In this case, the steady state S∗7 has T ∗nor
and T ∗aut satisfying the following system of equations
αcµaρ2σ2(βk + c)(T
∗
aut)
2T ∗nor + αcρ2(βkµaσ1 + cµFσ2 + cµaσ1)T ∗aut(T ∗nor)2
−(αβckdidnµa + β2k2dinρ2σ2 + αβckρ2σ2 − αc2dFρ2σ2 + αc2didnµa)T ∗aut
T ∗nor + αcdidinµap2(βk + c)T ∗aut + αc2µFρ2σ1(Tnor)3 − (β2k2dinρ2σ1
+αβckρ2σ1 − αc2dFρ2σ1 + αc2didnµF )(T ∗nor)2 + di(αc2dinµF p2
+β2k2dindn + αβckdn − αc2dFdn)T ∗nor − αcdidinp2(cdF − kβ) = 0,
p2ρ1ρ3σ2
2(T ∗aut)3 + σ2(−δdip1ρ2 + p1ρ1ρ2σ2 + p2ρ1ρ2σ2 + 2p2ρ1ρ3σ1
−ρ1ρ2σ2)(T ∗aut)2T ∗nor − dip2σ2(daρ1 + drρ3)(T ∗aut)2 + σ1(−δdip1ρ2
+2p1ρ1ρ2σ2 + 2p2ρ1ρ2σ2 + p2ρ1ρ3σ1 − 2ρ1ρ2σ2)T ∗aut(T ∗nor)2 + di(δdidnp1
−dap2ρ1σ1 − dnp1ρ1σ2 − dnp2ρ1σ2 − drp1ρ2σ2 − drp2ρ2σ2 − drp2ρ3σ1
+dnρ1σ2 + drρ2σ2)T
∗
autT
∗
nor + p2di
2(δλr + dadr)T
∗
aut + (1− p1 − p2)T ∗nor[−ρ1ρ2σ12(T ∗nor)2 + diσ1(dnρ1 + drρ2)T ∗nor − di2dndr] = 0,
with the rest of state variables being given by
I∗ =
σ1T
∗
nor + σ2T
∗
aut
di
, A∗ =
c (dF + µFT
∗
nor + µaT
∗
aut)
kβ
, V ∗ =
1−A∗ − µaT ∗aut
β
,
F ∗ =
cV ∗
k
, T ∗in =
din
din + αF ∗
, T ∗reg =
λr + p1αT
∗
inF
∗
dr − ρ1I∗ .
It does not prove possible to analyse stability of this steady state analytically, hence, one has to resort
to numerical calculations.
Remark. Inclusion of a term corresponding to production of autoreactive T cells directly from normal
activated T cells in a manner similar to Blyuss and Nicholson [51, 52] would make the steady states
S∗3 and S∗4 infeasible, while having no major effect on stability of other steady states. Hence, it suffices
to consider the above model without explicitly modelling the transition from Tnor to Taut.
4 Numerical stability analysis and simulations
To investigate various dynamical scenarios that can be exhibited by the model, we now perform a
comprehensive numerical analysis of stability of different steady states and identify their possible
bifurcations. Analytical results from the previous section suggest that the disease-free steady state
S∗2 is stable when kβ < cdF , and unstable when kβ > cdF . As will be shown below, there are some
major differences in dynamics between these two parameter combinations, hence, we will analyse
them separately. Since there are significant differences in the reported values of many of the model
parameters, and some of them have not yet been properly measures, we fix the baseline values as given
in Table 1, and perform a sweep of parameter space to identify the effects of varying these parameters.
Since prior to the start of infection, the numbers of infected cells, normal activated T cells, and the
amount of IL-2 are all equal to zero, the initial condition for the model is taken to be
(A(0), F (0), Tin(0), Treg(0), Tnor(0), Taut(0), I(0), V (0)) = (0.9, 0, 0.8, 0.7, 0, 0, 0, 0.4), (3)
which indicates the presence of some number of free virus particles. Here the initial values of A(0)
and Tin(0) are chosen randomly, with the only requirement that they do not exceed unity, in light of
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Parameter Value Definition
β 3 Infection rate
µa 20 The rate of killing of uninfected cells by autoreactive T cells
dF 1.1 Natural death rate of infected cells
µF 6 The rate of killing of infected cells by the normal T cells
din 1 Growth rate of na¨ıve T cells
α 0.4 Rate of activation of na¨ıve T cells by infected cells
λr 3 Growth rate of regulatory T cells
dr 0.4 Natural death rate of regulatory T cells
p1 0.4 Rate of conversion of na¨ıve T cells into regulatory T cells
p2 0.4 Rate of conversion of na¨ıve T cells into normal T cells
ρ1 10 Proliferation rate of regulatory T cells by interleukin 2 (IL-2)
ρ2 0.8 Proliferation rate of normal T cells by interleukin-2 (IL-2)
ρ3 2 Proliferation rate of autoreactive T cells by interleukin 2 (IL-2)
dn 1 Natural death rate of normal T cells
da 0.001 Natural death rate of autoreactive T cells
δ 0.002 Rate of clearance of autoreactive T cells by regulatory T cells
σ1 0.15 Rate of production of interleukin-2 (IL-2) by normal T cells
σ2 0.2 Rate of production of interleukin-2 (IL-2) by autoreactive T cells
di 0.6 Natural clearance rate of IL-2
k 2 Rate of production of free virus
c 6 Natural clearance rate of free virus
Table 1: Table of parameters
the fact that we are considering a non-dimensionalised model. For analysis of basins of attraction,
the values of Treg(0) and V (0) will be varied. Figure 2 illustrates how system dynamics is affected by
the parameters. Since the condition kβ < cdF holds, the disease-free steady state S
∗
2 is always stable.
However, the system can also have two other biologically feasible steady states S∗5 and S∗6 , which only
exist, provided regulatory T cells do not grow too rapidly and do not clear autoreactive T cells too
quickly. In the case where autoreactive T cells are very effective in killing infected cells (i.e. for higher
µa), or when they are producing IL-2 at a slow rate (smaller σ2), only the steady state S
∗
5 is feasible,
which has the zero population of host cells A, while the steady state S∗6 with A > 0 can only exist
when µa is relatively low (or σ2 is high), and S
∗
5 is unstable. Provided the steady states S
∗
5 and S
∗
6 are
feasible, decreasing the growth rate λr of regulatory T cells results in a supercritical Hopf bifurcation,
which gives rise to stable periodic solutions around these steady states. Since the steady state S∗5 is
characterised by A = 0, both regimes where this steady state is stable, or unstable with oscillations
around it, biologically correspond to a situation where the host cells are dead. On the other hand, a
periodic solution around S∗6 corresponds to a proper autoimmune response, whereby the infection is
cleared, but the immune system still exhibits endogenous oscillations, as illustrated in Fig. 4(a)-(b).
At the intersection of the lines of Hopf bifurcation and the steady-state bifurcation, one has the fold-
Hopf (also known as zero-Hopf or saddle-node Hopf) bifurcation [96]. Importantly, the steady states
S∗5 and S∗6 can only exist if the rate ρ3 at which IL-2 promotes proliferation of autoreactive T cells is
sufficiently high, and this minimum value of the rate ρ3 increases linearly with the rate ρ1 at which
IL-2 promotes proliferation of regulatory T cells. Once feasible, the steady states S∗5 and S∗6 are stable
for smaller values of ρ3 and then undergo Hopf bifurcation, when ρ3 is sufficiently increased.
Since for all parameter combinations in Fig. 2 the steady state S∗2 is stable, this means that the
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Figure 2: Regions of feasibility and stability of the steady states S∗5 and S∗6 with parameter values from
Table 1. Black and red curves indicate the boundaries of feasibility and the steady-state bifurcation,
whereas dashed lines (blue/brown) show the boundaries of Hopf bifurcation of the steady states S∗5 and
S∗6 , respectively, with ‘fH’ indicating the fold-Hopf bifurcation. The first digit of the index refers to
S∗5 , while the second corresponds to S∗6 , and they indicate that in that parameter region the respective
steady state is unfeasible (index is ‘0’), stable (index is ‘1’), unstable via Hopf bifurcation with a
periodic orbit around this steady state (index is ‘2’), or unstable via a steady-state bifurcation (index
is ‘3’). In all plots, the condition kβ < cdF holds, so the disease-free steady state S
∗
2 is also stable.
system can exhibit bi-stability between steady states and/or periodic solutions. To investigate this in
more detail, we choose parameter values in the ‘32’ region in Fig. 2, where periodic oscillations around
the steady state S∗6 are possible. While previous work on multi-stability in models of autoimmunity
focussed mainly on identifying parameter regions associated with bi-stability [70, 72, 69], the structure
of basins of attraction associated with different dynamical states has remained largely unexplored. To
analyse basins of attraction in our model, due to high dimensionality of the phase space, we fix initial
conditions for all state variables, and consider different initial amounts of free virus V (0) and regulatory
T cells Treg(0), as illustrated in Fig. 4. Biologically, this corresponds to varying the initial level of
infection, as well as the initial state of the immune system, which can be primed by previous exposures
to other pathogens. This Figure shows that if the initial number of regulatory T cells is sufficiently
high, the system is able to successfully eliminate infection without any lasting consequences, settling
on a stable disease-free steady state. Interestingly, for very small initial amounts of free virus, a higher
amount of regulatory T cells is required to clear the infection. For lower values of Treg(0), the system
exhibits stable periodic oscillations around the steady state S∗6 , which biologically represents the regime
of autoimmune response. One can also observe that the minimum value of Treg(0) needed to achieve
a diease-free steady state reduces with increasing the rate µF at which normal T cells are able to
kill infected cells. Figure 4 illustrates temporary evolution of the system in the regime of bi-stability
between a stable disease-free steady state and a periodic solution, corresponding to autoimmunity.
The dynamics of regulatory T cells (not shown in this figure) mimics that of autoreactive T cells.
Next, we consider a situation described by the combination of parameters satisfying kβ > cdF , so
the disease-free steady state S∗2 is unstable, and the system can only have steady states S∗5 , S∗6 , and S∗7 .
Figure 5 shows how feasibility and stability of these steady states depend on parameters. Naturally,
this figure is identical to Fig. 2 in terms of indicating stability and bifurcations of the steady states
S∗5 and S∗6 . One should note that unlike the case considered earlier, now for sufficiently high rate σ2
of production of IL-2, or sufficiently small rate µa at which autoreactive T cells are killing infected
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Figure 3: Regions of bi-stability with parameter values from Table 1 and initial condition (3). (a),
(b) λr = 2.5, µa = 5, with µF = 10 (black), µF = 20 (blue), µF = 30 (red). The system exhibits
autoimmune response to the right of the surface in (a) and below the curves in (b), while to the left of
the surface in (a) and above the curves in (b) it tends to a stable disease-free steady state S∗2 . (c), (d)
ρ1 = 30, ρ3 = 8. The system exhibits autoimmune response inside the region bounded by the surfaces
in (c), or by the curves in (d), and outside it tends to a stable disease-free steady state S∗2 .
cells, the steady state S∗6 can also undergo a steady-state bifurcation due to the fact that the condition
kβ > cdF holds. Beyond this stability boundary, i.e. for very high values of σ2 or very small values of
µa, both steady states S
∗
5 and S
∗
6 are unstable, and the system settles either on the steady state S
∗
7 ,
or an a periodic solution around this steady state. In the parameter region, where only the steady
state S∗7 is feasible, this steady state can only be unstable, giving rise to stable periodic oscillations,
for sufficiently small values of δ or λr, whereas for higher values of those parameters this steady state
is stable.
Figure 6 demonstrates the basins of attraction of the steady states S∗5 , S∗6 and S∗7 , as well as
periodic solutions around them. As it has already been mentioned, this is the first time when basins
of attraction for different steady states and periodic solutions are identified in a model of cytokine-
mediated immune response and autoimmunity. Figure (a) shows that if the initial amount of free
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Figure 4: Simulation of the model (2) with parameter values from Table 1, except for λr = 2.5, µa = 5,
µF = 10, and the initial condition (3). (a), (b) V (0) = 10, Treg(0) = 100, the system exhibits periodic
behaviour around S∗6 , i.e. clearance of infection followed by the onset of autoimmune response. (c),
(d) V (0) = 10, Treg(0) = 150, the model converges to a stable disease-free steady state S
∗
2 .
virus is sufficiently small, the system will converge to S∗7 for any value of Treg(0). For higher values of
V (0), the system exhibits bi-stability, where for smaller initial numbers of regulatory T cells Treg(0) it
converges to the stable steady state S∗5 corresponding to the death of susceptible organ cells, while for
higher values of Treg(0), the system settles on the stable steady state S
∗
7 . While the critical value of
Treg(0) at which the transition between the two steady state takes place initially increases with V (0),
eventually it settles on some steady level, so that for higher initial amounts of free virus, this critical
value no longer depends on V (0). Figure (b) illustrates a qualitatively similar behaviour for higher
rates of production of IL-2 and clearance of autoreactive T cells, in which case there is a bi-stability
between S∗6 and S∗7 , but with the difference that there is also a small region for small values of Treg(0)
and intermediate values of V (0), where the system also converges to S∗7 . Figures (c) and (d) illustrate
bi-stability between a periodic solution around S∗7 and either the stable steady state S∗6 , or a periodic
solution around this steady state.
Numerical simulations in Figs. 7, 8, 9, and 10 show the dynamics of the model in the case when
kβ > cdF for the same parameter values but different initial conditions, thus illustrating various bi-
stability scenarios shown in Fig. 6, in which crosses indicate the values of specific initial conditions
used for simulations. Figure 7 demonstrates how for sufficiently small initial number of regulatory T
cells the infection can result in the death of organ cells, in which case the system approaches a stable
steady state S∗5 . On the other hand, for a higher number of Tregs, the system goes to a stable steady
state S∗7 which represents a persistent (chronic) infection. In this case, one observes some kind of
balance maintained with the help of regulatory T cells: while the immune system is not able to clear
the infection, at the same time it prevents infection from destroying the organ cells.
Figure 8 illustrates a similar behaviour, where bi-stability takes place between the steady states
S∗6 and S∗7 . In this case, for a smaller number of regulatory T cells, the system favours the regime
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Figure 5: Regions of feasibility and stability of the steady states S∗5 , S∗6 , and S∗7 with parameter values
from Table 1. Black and magenta curves indicates the boundaries of feasibility for S∗5/S∗6 and S∗7 ,
dashed curves are the boundaries of Hopf bifurcation for S∗5/S∗6 (blue/brown) or S∗7 (purple), and
dotted lines are the boundaries of the steady-state bifurcation of S∗5 (red) and S∗6 (green), with ‘fH’
indicating the location of the fold-Hopf bifurcation. The first digit of the index refers to S∗5 , the second
corresponds to S∗6 , and the third corresponds to S∗7 . These indices indicate that in that parameter
region the respective steady state is unfeasible (index is ‘0’), stable (index is ‘1’), unstable via Hopf
bifurcation with a periodic orbit around this steady state (index is ‘2’), or unstable via a steady-state
bifurcation (index is ‘3’). In all plots, the condition kβ > cdF holds, so the disease-free steady state
S∗2 is unstable.
of normal clearance of infection, where after the initial growth, the numbers of infected cells and
activated T cells responding to foreign antigen go to zero. For higher numbers of regulatory T cells,
the system again approaches a stable steady state S∗7 describing a persistent infection. This is a really
interesting and counter-intuitive result, which suggests that whilst regulatory T cells play a major
role in reducing autoimmune response during normal disease clearance, when they are present in high
numbers, the are actually promoting the persistence of infection.
Figure 9 illustrates a regime of bi-stability between periodic solutions around the steady states S∗6
and S∗7 . Similarly to the case of stable disease-free steady state considered earlier, the periodic solution
around S∗6 biologically corresponds to the regime of autoimmune response, where upon clearance of
the initial infection, the immune systems maintains endogenous oscillations, in which the growth of
autoreactive T cells results in the destruction of some healthy organ cells, after which the number of
autoreactive T cells
decreases, and the organ cells recover.
One should note that since these oscillations take place around the steady state S∗6 , the mean
concentration of organ cells is much lower than what it was before the infection. In the case of
periodic oscillations around the steady state S∗7 , initially one observes a similar behaviour in terms
of rapid growth of infected cells, followed by an expansion in the population of activated T cells
recognising foreign antigen, but after the number of infected cells decreases, rather than go to zero, it
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Figure 6: Regions of bi-stability in the system (2) with the initial condition (3), parameter values
from Table 1, and β = 4, k = 2.1. (a) δ = 0.002, σ2 = 0.2, (b) δ = 0.0024, σ2 = 0.5, (c) δ = 0.0017,
σ2 = 0.42, (d) δ = 0.0024, σ2 = 0.7. Green, blue and yellow are the basins of attraction of the steady
states S∗5 , S∗6 , and S∗7 , respectively. Grey and pink are the basins of attraction of periodic solutions
around S∗6 and S∗7 , respectively.
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Figure 7: Numerical solution of the model (2) with the initial condition (3), parameter values from
Table 1, and β = 4, k = 2.1, δ = 0.002, σ2 = 0.2. In (a) and (b) V (0) = 10 and Treg(0) = 25. The
model converges to the S∗5 . In (c) and (d) V (0) = 10 and Treg(0) = 45. The model converges to the
S∗7 . The dynamic of Treg has a same behaviour as Taut.
settles on periodic oscillations around some small positive level. This suggests that the infection is not
cleared, but rather than being chronic, there are intervals of quiescence where the level of infection is
very small, followed by regular intervals of rapid growth of infection and autoreactive T cells, which
causes significant reduction in the number of uninfected organ cells. After this infection is significantly
reduced by the activated T cells, the cycle repeats.
Finally, Figure 10 demonstrates a situation where the system has a bi-stability between a stable
steady state S∗6 and a periodic solution around S∗7 . The difference from the previous case is that
instead of autoimmune regime, the system can now successfully clear the infection, without having any
subsequent oscillations. Although the infection itself is cleared, it leaves an imprint on the dynamics
in the form of a reduced number of organ cells and a non-zero number of autoreactive T cells.
5 Discussion
In this paper we have developed and studied a model of immune response to a viral infection, with
an emphasis on the role of cytokine mediating T cell activity, and T cells having different activation
thresholds. Stability analysis of the model’s steady states has allowed us to identify regimes with
different dynamical behaviour depending on system parameters. When the product of infection rate
and the rate of production of new virus particles is smaller than the product of the rates of viral
clearance and death of infected cells, the immune system is able to successfully clear the infection
without further consequences for either the host organ cells, or the immune system. In this case,
the system settles on a stable disease-free steady state, characterised by the absence of infected cells
and free virus, as well as zero amount of normal or autoreactive T cells. Another biologically feasible
steady state that can exist in some parameter regimes is the state that also has no infected cells or
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Figure 8: Numerical solution of the model (2) with the initial condition (3), parameter values from
Table 1, and β = 4, k = 2.1, δ = 0.0024, σ2 = 0.5. (a), (b) V (0) = 10, Treg(0) = 80. The system
converges to S∗6 . (c), (d) V (0) = 10, Treg(0) = 130. The system converges to S∗7 . The dynamics of
Treg is the same as Taut.
free virus, but maintains non-zero levels of activated T cells. We have derived analytical conditions
for steady-state and Hopf bifurcations of this state. When the disease-free steady state is unstable,
the model also possesses a steady state with all cell populations being positive, which biologically
corresponds to a state of chronic infection.
To investigate how the system behaves in different parameter regimes, we have solved it numerically,
paying particular attention to cases where more than one steady state can be feasible. This has allowed
us to identify regions of multi-stability, where for the same parameter values, depending on the initial
conditions the system can approach either two distinct steady states, or a steady state and a periodic
solution. In the case where the disease-free steady state is stable, such a regime has a very important
potential clinical significance, as effectively it suggests that whether or not a given patient is able to
clear the infection or will go on to develop autoimmunity depends not only on the rate of performance
of their immune system, but also on the magnitude of viral challenge they experience and the amount
of regulatory T cells they have before the infection. Numerical simulations for the autoimmune regime
illustrate how initial infection leads to a rapid growth in the number of infected cells, resulting in the
growth of populations of normal and autoreactive T cells, which clear the infection, but on a longer
time-scale the system exhibits sustained periodic oscillations that can be associated with periods of
relapses and remission, characteristic for many autoimmune diseases. For the case where the disease-
free steady state is unstable, the bi-stability can occur between an autoimmune steady state and
a chronic state, or a period orbit around the latter. A number of earlier models have looked into
bi-stability in the immune dynamics, and the model analysed in this paper provides further clues
regarding the important role played by cytokines in controlling the dynamics of immune response. In
the regime of bi-stability, we have discovered that the initial state of the immune system, and the
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Figure 9: Numerical solution of the model (2) with the initial condition (3), parameter values from
Table 1, and β = 4, k = 2.1, δ = 0.0017, σ2 = 0.42. (a), (b) V (0) = 0.3, Treg(0) = 600. This
system exhibits periodic oscillations around S∗6 , i.e. an autoimmune response. (c), (d) V (0) = 9,
Treg(0) = 600. The system exhibits periodic oscillations around S
∗
7 . The dynamics of Treg is the same
as Taut.
initial viral load determine the course and outcome of the immune response, a result that would be
interesting to test in an experimental setting.
There are several directions in which the model presented in this paper could be extended to
make it more realistic. One possibility is to include in the model other potentially relevant aspects
of immune system dynamics, such as memory T cells [97, 98], or the effects of T cells on secretion
of IL-2 [84, 95]. Another aspect that is particularly relevant for our model is the fact that activation
thresholds can themselves change during the process of immune response, hence, one could explicitly
include the dynamics of activation thresholds as an extra component of the model [38, 41, 42, 43].
Many viruses are known to have a non-negligible lag phase in their virus cycle, which includes such
processes as virus attachment, cell penetration and uncoating, virus assembly, maturation, and release
of new virions. All these processes result in the delay in production and release of new virus particles,
thus having an impact on the dynamics of immune response and potential onset and development
of autoimmune disease. Mathematically, the lag phase can be represented using time delays in the
relevant terms of the model, and the available data on lag phase for viruses associated with triggering
or exacerbating autoimmune diseases can be used to validate the model.
Due to the large dimension of the phase space of model (2), and the complex structure of basins of
attraction for different steady states and periodic solutions illustrated above, it would be important to
more systematically investigate the issue of multi-stability in the system. One very promising approach
to address this challenging problem is that of offset boosting [99, 100, 101, 102]. The underlying idea is
that provided the model has the property that ensures that the functional form of equations remains
the same when one of the state variables is shifted by a constant, this would imply that the system
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Figure 10: Numerical simulation of the model (2) with the initial condition (3), parameter values from
Table 1, and β = 4, k = 2.1, δ = 0.0024, σ2 = 0.7. (a), (b) V (0) = 0.05, Treg(0) = 300. The system
converges to S∗6 . (c), (d) V (0) = 9, Treg(0) = 300. The system exhibits periodic oscillations around
S∗7 . The dynamics of Treg is the same as Taut.
is variable-boostable, and it can then be transformed into a system with conditional symmetry [102],
implying that the new system is symmetric subject to a certain condition on the boosting. The
importance of this conditional symmetry is two-fold. On the one hand, it provides a robust handle
on identification of symmetric attractors in the system [102], which otherwise may not be apparent,
especially due to a large dimensionality of the phase space. On the other hand, this methodology
yields an effective tool for identifying multi-stability and exploring basins of attraction for different
dynamical states, by allowing the system to visit different basins of attraction with the same initial
condition by means of offset boosting [101]. Future work will explore model (2) from the perspective of
conditional symmetry to identify all parameter regions associated with multi-stability and to delineate
associated basins of attraction. This will provide significant practical insights for monitoring of onset
and progress of autoimmune disease.
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